tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT05225233
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Sham Transcranial Direct Current Stimulation (tDCS) — DEVICECognitive training concurrent with sham tDCS (30 seconds ramp up/ramp down at the beginning of the session)
- Active Transcranial Direct Current Stimulation (tDCS) — DEVICECognitive training concurrent with 2 mAmps of anodal stimulation applied to the left frontal cortex for 20 minutes.
Study Details
The purpose of this study is to investigate if transcranial direct current stimulation (tDCS) can increase the effectiveness of cognitive training to reduce impulsivity in individuals with obesity, and to evaluate weight change with these individuals. The long-term goal of this research is to develop new treatment approaches for individuals with obesity.
Key Dates
- Start date
- Nov 23, 2022
- Status verified
- Mar 2026
- Primary completion
- Aug 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 124 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Active tDCS with Cognitive TrainingParticipants will receive active tDCS stimulation with their cognitive training during a one-hour session each day which includes 20 minutes of stimulation at the beginning of a 46-minute task training session. Ten sessions will be completed over three weeks.
- Sham Comparator: Sham tDCS with Cognitive TrainingParticipants will receive 10 sessions of cognitive training concurrent with sham tDCS. For sham tDCS, electrodes are placed at the same locations as for active tDCS, but current is ramped up for the initial 30 seconds, then immediately ramped back down. This method mimics the initial physical sensation of stimulation, but there is no active current for the remainder of the session.
Primary Outcome Measure
Change in task impulsivity as measured by the NIH Flanker [ Time Frame: Change between baseline and Visit 11, Visit 12 (approximately 2 months), and Visit 13 (approximately 4 months) ]
Central Contacts
- Shalamar D Sibley, MD(612) 725-2000
- Lisa E Keacher, BS(612) 467-5203
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Minneapolis VA Health Care System, Minneapolis, MN | Minneapolis | Minnesota | 55417-2309 | Shalamar D Sibley, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Minneapolis, MN
By condition
By specialty
Related Studies
- Insulin Regulation of Lipolysis and Lipolysis ProteinsEARLY_PHASE1 · Recruiting · Mayo Clinic · Rochester, Minnesota
- Evaluating Benefit of Peptide Based Diet in Obese HEN PatientsEnrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Caloric Restriction and Activity to Reduce Chemoresistance in B-ALLPHASE2 · Recruiting · Etan Orgel · Los Angeles, California
- Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection FractionPHASE2 · Enrolling By Invitation · Mayo Clinic · Rochester, Minnesota